Prostate cancer: Comparing quality of life outcomes after prostate cancer treatment


as the most common solid malignancy in men in the USA1; thus, the comparison of management options for localized prostate cancer has entered a new era of scrutiny. In particular, the recent publication of the ProtecT study2 has reintroduced the notion of comparison of oncological outcomes between multiple treatment modalities. However, life expectancy after… (More)
DOI: 10.1038/nrurol.2017.81


  • Presentations referencing similar topics